secwatch.observer — SEC 8-K summary
======================================

Issuer:     MADRIGAL PHARMACEUTICALS, INC. (MDGL)
CIK:        0001157601
Form:       8-K
Filed at:   2025-03-11T23:59:59+00:00
Accession:  0001193125-25-051461
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Madrigal appoints Jackie Fouse to Board; Fred Craves to retire in July 2025
---------------------------------------------------------------------------

- Fred Craves, Ph.D. resigns from Madrigal's Board effective July 1, 2025; no disagreement cited.
- Board expanded to 10 members; Jacqualyn Fouse, Ph.D. elected to fill new vacancy on March 10, 2025.
- Fouse to serve on Audit and Nominating & Governance Committees; receives annual cash retainer of $50,000 plus committee fees.
- Fouse granted $600,000 equity award (50% options, 50% RSUs) vesting over two years; prorated annual director award also granted.
- Fouse is former CEO of Agios Pharmaceuticals and current Chair of Agios Board; over 30 years healthcare experience.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1157601/000119312525051461/0001193125-25-051461-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1157601/000119312525051461/d916063d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-051461

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer